Description
PT-141 / Oxytocin combines PT-141 (15mg), a cyclic analog of alpha-MSH that acts at melanocortin receptors, with Oxytocin (2.5mg), a nine-residue pituitary hormone, in one preparation. It serves as a reference blend for dual-peptide receptor studies.
In cell culture and laboratory animal studies, research has covered MC4 receptor activation, oxytocin receptor pharmacology, and neuropeptide pathway interactions in hypothalamic tissue. The combined format supports side-by-side receptor experiments.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.